XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Note 9 - Cash Equivalents, Investments and Restricted Cash
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]

9. CASH, CASH EQUIVALENTS, INVESTMENTS AND RESTRICTED CASH

 

The following is a summary of the Company’s cash, cash equivalents and debt investments (in thousands): 

 

  

March 31,

  

December 31,

 
  

2021

  

2020

 

Cash

 $197,744  $300,609 

Money market funds

  20,624   34,335 

Certificates of deposit

  106,763   - 

Corporate debt securities

  306,201   249,671 

Commercial paper

  -   2,999 

U.S. treasuries and government agency bonds

  7,491   7,499 

Auction-rate securities backed by student-loan notes

  2,820   2,861 

Total

 $641,643  $597,974 

 

  

March 31,

  

December 31,

 
  

2021

  

2020

 

Reported as:

        

Cash and cash equivalents

  218,368   334,944 

Short-term investments

  420,455   260,169 

Debt investment within other long-term assets

  2,820   2,861 

Total

 $641,643  $597,974 

 

The following table summarizes the contractual maturities of the short-term and long-term available-for-sale investments as of March 31, 2021 (in thousands):  

 

  

Amortized Cost

  

Fair Value

 

Due in less than 1 year

 $89,085  $89,289 

Due in 1 - 5 years

  330,053   331,166 

Due in greater than 5 years

  2,995   2,820 

Total

 $422,133  $423,275 

 

Gross realized gains and losses recognized on the sales of available-for-sale investments were not material for any of the periods presented. 

 

The following tables summarize the unrealized gain and loss positions related to the available-for sale investments (in thousands): 

 

  

March 31, 2021

 
  

Amortized Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Money market funds

 $20,624  $-  $-  $20,624 

Certificates of deposit

  106,763   -   -   106,763 

Corporate debt securities

  304,876   1,611   (286)  306,201 

U.S. treasuries and government agency bonds

  7,499   -   (8)  7,491 

Auction-rate securities backed by student-loan notes

  2,995   -   (175)  2,820 

Total

 $442,757  $1,611  $(469) $443,899 

 

  

December 31, 2020

 
  

Amortized Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Money market funds

 $34,335  $-  $-  $34,335 

Corporate debt securities

  247,591   2,177   (97)  249,671 

Commercial paper

  2,999   -   -   2,999 

U.S. treasuries and government agency bonds

  7,499   2   (2)  7,499 

Auction-rate securities backed by student-loan notes

  3,020   -   (159)  2,861 

Total

 $295,444  $2,179  $(258) $297,365 

 

The following tables present information about the available-for-sale investments that had been in a continuous unrealized loss position for less than 12 months and for greater than 12 months (in thousands): 

 

  

March 31, 2021

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

 

Corporate debt securities

 $152,871  $(286) $-  $-  $152,871  $(286)

U.S. treasuries and government agency bonds

  7,491   (8)  -   -   7,491   (8)

Auction-rate securities backed by student-loan notes

  -   -   2,820   (175)  2,820   (175)

Total

 $160,362  $(294) $2,820  $(175) $163,182  $(469)

 

  

December 31, 2020

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

 

Corporate debt securities

 $59,144  $(97) $-  $-  $59,144  $(97)

U.S. treasuries and government agency bonds

  5,998   (2)  -   -   5,998   (2)

Auction-rate securities backed by student-loan notes

  -   -   2,861   (159)  2,861   (159)

Total

 $65,142  $(99) $2,861  $(159) $68,003  $(258)

 

An impairment exists when the fair value of an investment is less than its amortized cost basis. As of March 31, 2021 and December 31, 2020, the Company did not consider the impairment of its investments to be a result of credit losses. The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. When evaluating a debt security for impairment, management reviews factors such as the Company’s intent to sell, or whether it will more likely than not be required to sell, the security before recovery of its amortized cost basis, the extent to which the fair value of the security is less than its cost, the financial condition of the issuer and the credit quality of the investment.

 

The Company’s auction-rate securities are backed by pools of student loans supported by guarantees by the U.S. Department of Education. The underlying maturities of these securities are up to 25 years.  The Company has received all scheduled interest payments on a timely basis pursuant to the terms and conditions of the securities. The Company does not intend to sell these securities, and it is more likely than not that the Company will not be required to sell these securities, before recovery of its amortized cost basis. To date, the Company has redeemed $40.3 million, or 93% of the original portfolio in these auction-rate securities, at par without any realized losses.

 

Non-Marketable Equity Investment

 

In  November 2020, the Company made an equity investment in a privately held Swiss company (the “Investee”) that is accounted for under the measurement alternative. One member of the Company’s Board of Directors is an executive officer of a company that has a commercial relationship with the Investee. In addition, the Company’s Chief Executive Officer has a personal investment in the Investee. As of  March 31, 2021 and December 31, 2020, the Company’s investment in the Investee, which is denominated in CHF, had a carrying value of $3.2 million and $3.4 million, respectively. The Company did not record any impairment or adjustments resulting from observable price changes for the three months ended March 31, 2021.

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the amounts reported on the Condensed Consolidated Statements of Cash Flows (in thousands):   

 

  

March 31,

  

December 31,

 
  

2021

  

2020

 

Cash and cash equivalents

 $218,368  $334,944 

Restricted cash included in other long-term assets

  119   127 

Total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Statements of Cash Flows

 $218,487  $335,071 

 

As of March 31, 2021 and December 31, 2020, restricted cash included a security deposit that is set aside in a bank account and cannot be withdrawn by the Company under the terms of a lease agreement. The restriction will end upon the expiration of the lease.